Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2008
11/04/2008US7445914 Animal product free media and processes for obtaining a botulinum toxin
11/04/2008US7445913 Recombinant cell comprising expression vector; transcription; new cytokine that stimulates hematopoietic cells
11/04/2008US7445895 Amplifying CDNA, hybridizing, adding blocking solution and avidin enzyme or streptavidin horseradish peroxidase; detecting luminescence or color change; fast detection in less than 5 hours
11/04/2008US7445775 Mammalian nucleotide sequence coding plasminogen catalytic domain and optionally kringle domains linked to promoter; ischemic stroke, arterial thrombotic diseases
11/04/2008CA2602062A1 Apparatus for and method of denitrifying a solution
11/04/2008CA2192849C Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
11/03/2008CA2685746A1 In vitro model of latent mycobacterial infection
10/2008
10/30/2008WO2008131359A1 Genetically modified biological cells
10/30/2008WO2008131339A1 Microbial host-vector complementation system
10/30/2008WO2008131286A1 Engineered microorganisms for producing isopropanol
10/30/2008WO2008131014A1 Lipopeptides and lipopeptide synthetases
10/30/2008WO2008130995A2 Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes
10/30/2008WO2008130917A1 Composition comprising various salmonella subspecies and method for controlling intestinal pathogenic organisms
10/30/2008WO2008130701A1 Biofertilizer formulation
10/30/2008WO2008130603A2 Increased ethanol production from xylose
10/30/2008WO2008130551A2 Antibiotic resistance free listeria strains and methods for constructing and using same
10/30/2008WO2008130437A2 Modified cyanobacteria
10/30/2008WO2008130372A2 Production of sterols in oleaginous yeast and fungi
10/30/2008WO2008130262A1 Rhodococcus erythropolis strains for biodegrading mustard hydrolysis products and pseudomonas putida strains for biodegrading mustard hydrolysis products and a method for biodegrading soil
10/30/2008WO2008130053A1 Fused protein comprising protein g with avidin
10/30/2008WO2008130034A1 Polyamino acid synthetase and gene encoding the same
10/30/2008WO2008129971A1 Improved persistently infective sendai virus vector
10/30/2008WO2008129934A1 Astaxanthin-producing bacterium, bacterial culture, astaxanthin-containing composition and method of producing astaxanthin
10/30/2008WO2008129873A1 Phenylalanine aminomutase with selectivity for s-form, dna encoding the same, method for producing (s)-β-phenylalanine and method for producing (s)-β-phenylalanine analogs
10/30/2008WO2008129841A1 Composition comprising lactic acid bacterium having high anti-allergic activity, and method for production of the lactic acid bacterium
10/30/2008WO2008129699A1 Chimeric fusicoccane synthase and gene of the same
10/30/2008WO2008129422A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008WO2008128522A2 Microorganism for the production of succinic acid
10/30/2008WO2008109659A3 Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of cells
10/30/2008WO2008103471A3 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/30/2008WO2008097817A3 Multivariable antigens complexed with targeting humanized monoclonal antibody
10/30/2008WO2008073914A3 Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi
10/30/2008WO2008028024A3 Automated parallel oligonucleotide synthesis
10/30/2008WO2006116487A3 Polypeptides and biosynthetic pathways for the production of monatin and its precursors
10/30/2008US20080271207 Lipase Polypeptide
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080269537 Crustacean metallothionein polypeptide; bioremediation; pollution control
10/30/2008US20080269465 Tumor necrosis factor specific immunoglobulin for use in prevention and treatment of rheumatoid arthritis, ulcerative colitis, multiple sclerosis and crohn's disease
10/30/2008US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/30/2008US20080269139 FGF-5 Supported and Binding Peptides
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269113 P53 binding t cell receptor molecules
10/30/2008US20080269071 Pseudopterosin-producing bacteria and methods of use
10/30/2008US20080268541 Attenuated Mycobacteria as Vectors for Gene Delivery to Mammalian Cells
10/30/2008US20080268539 Synthesis of Long-Chain Polyunsaturated Fatty Acids by Recombinant Cells
10/30/2008US20080268527 Mutant bacterial strains of the genus sphingomonas deficient in production of polyhydroxybutyrate and a process of clarification of sphingans and compositions thereof
10/30/2008US20080268524 Inoculating nutrient broth with inert gas, hydrogen and carbon dioxide mixture, freeze drying, recovering bacteria
10/30/2008US20080268523 Using vector transformation to generate transgenic organism which can express heterologous protein in high and low temperatures
10/30/2008US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
10/30/2008US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
10/30/2008US20080268517 Recombinant cytochrome comprising heme and reductase domains for use as screening tool in monitoring drug efficacy, toxicity and pharmacokinetic profiles; directed protein evolution
10/30/2008US20080268514 Liquid matrix dissolved or dissociated in biocompatible solvent and stabilizer in contact without refrigeration for one day
10/30/2008US20080268513 and/or proteins derived from microorganisms to separate isotopes of actinide elements such as uranium, resulting in enrichment for the lighter isotope (235U)
10/30/2008US20080268507 Recombinant Dna Nicking Endonuclease and Uses Thereof
10/30/2008US20080268502 Multiple Promoters and the Use Thereof For Gene Expression
10/30/2008US20080268501 Methods and materials relating to gene expression
10/30/2008US20080268500 Capable synthesising mono-, bi- and/or tri-cyclic sesquiterpenes having a C2-C7 or a C3-C7 bond, via farnesyl-pyrophosphate precursor; for catalyzing cyclisation to the santalene and bergamotene carbon skeletons
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268475 Transgenic saccharomyces comprising orphan receptors for use in monitor drug binding affinities; drug screening
10/30/2008US20080268455 Detection of nuceic acids by multiple sequential invasive cleavages
10/30/2008US20080268438 Model system for identifying anti-cancer agents
10/30/2008US20080268099 For use as infant food; liquid or powdered form; bioconversion on a milk substrate with aid of a Bifidobacterium culture by keeping in contact with culture, under conditions which are unfavorable to fermentation by Bifidobacterium
10/30/2008US20080268096 Rupturing yeast cells and generating a mixture of cell wall ghosts and cytoplasm for use as nutritional supplement to animal feeds
10/30/2008US20080268006 Probiotic Lactobacillus Strains for Improved Vaginal Health
10/30/2008US20080267998 Combinations of gene deletions for live attenuated shigella vaccine strains
10/30/2008US20080267990 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection
10/30/2008US20080267985 Major allergen Phl p 1 comprising reduced immunoglobulin reactivity for use in treating grass pollen allergies; immunotherapy
10/30/2008US20080267974 Tumor necrosis factor specific immunoglobulin for use in diagnosis and treatment of autoimmune diseases
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267937 Compositions for Preventing Plant Disease Comprising Bacillus Subtilis Kccm 10639 or Kccm 10640 and Methods of Preventing Plant Disease by Using Them
10/30/2008US20080267932 Lactobacillus Rhamnosus with Body-Fat Reducing Activity and the Foods Containing Them
10/30/2008US20080267930 Biological Materials and Uses Thereof
10/30/2008US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide
10/30/2008US20080265206 Enzymatic conversion of 5-norbornene-2-carbonitrile to give 5-norbornene-2-carboxylic acid with a high substrate concentration; nucleic acid encoding said polypeptide; suitable for preparation of cyclic olefin copolymers, pharmaceutical intermediates, pesticides or fragrances
10/30/2008US20080264858 Delivery systems for mycotechnologies, mycofiltration and mycoremediation
10/30/2008DE112004002508B4 Der neue Bacillus Amyloliquefaciens KTGB202 und Verfahren zur Eindämmung von Pflanzenpathogenen Pilzen unter Verwendung von selbigem The new Bacillus amyloliquefaciens KTGB202 and methods for control of fungal plant pathogens using selbigem
10/30/2008CA2721392A1 Microorganism for the production of succinic acid
10/30/2008CA2686393A1 Composition comprising lactic acid bacterium having high anti-allergic activity, and method for production of the lactic acid bacterium
10/30/2008CA2684834A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008CA2684617A1 Biofertilizer formulation
10/30/2008CA2666968A1 Modified cyanobacteria
10/30/2008CA2659603A1 Oil producing microbes and methods of modification thereof
10/29/2008EP1985707A1 Method for the deletion of a large chromosomal region
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985704A1 Flavonoid glycosyltransferase and utilization thereof
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985701A2 Genes differentially expressed in breast cancer
10/29/2008EP1985700A1 Novel (s,s)-butanediol dehydrogenase, gene for the same, and use of the same
10/29/2008EP1985695A1 Recombinant microorganism
10/29/2008EP1985630A2 T1R taste receptors and genes encoding same
10/29/2008EP1985626A1 P. gingivalis antigenic composition
10/29/2008EP1984514A2 Systems and methods for producing biofuels and related materials
10/29/2008EP1984128A1 Metagenome
10/29/2008EP1984021A2 Viable non-toxic gram negative bacteria
10/29/2008EP1669445B1 Novel vector and utilization of the same
10/29/2008EP1297145B1 Streptococcus pyogenes antigen
10/29/2008EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
1 ... 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 ... 1489